File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Guidelines for the administration of hormone replacement therapy. The Hong Kong College of Obstetricians and Gynaecologists

TitleGuidelines for the administration of hormone replacement therapy. The Hong Kong College of Obstetricians and Gynaecologists
Authors
KeywordsEstrogen replacement therapy
Hong Kong
Practice guidelines
Issue Date1999
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk
Citation
Hong Kong Medical Journal, 1999, v. 5 n. 2, p. 195-199 How to Cite?
AbstractObjective. To establish guidelines on the administration of hormone replacement therapy in Hong Kong for a primary audience of Fellows and Members of the Hong Kong College of Obstetricians and Gynaecologists and a secondary audience of all interested medical and paramedical personnel in Hong Kong. Participants. The Quality Assurance Committee established a consensus panel of four College Fellows who had expertise of treating menopausal women by giving hormone replacement therapy. All the panelists were qualified obstetricians and gynaecologists. Evidence. The panelists drew their conclusions from the available scientific literature on hormone replacement therapy from Hong Kong and overseas. Consensus process. The consensus reached within the panel was presented to the Quality Assurance Committee on 23 June 1998, and subsequently revised and presented three times. The final version was approved by the Quality Assurance Committee on 2 March 1999 and the Council of the Hong Kong College of Obstetrics and Gynaecology on 11 March 1999. Conclusions. The administration of hormone replacement therapy is effective in reducing the severity and frequency of menopausal hot flushes and sweating. Therapy protects against osteoporosis and reduces the risk of cardiovascular disease. There is some evidence to suggest that treatment also protects against Alzheimer's disease and carcinoma of the colon. The most serious problem attributed to using hormone replacement therapy is the possible increase in the risk of breast cancer development; the exact risk is unknown. Side effects include unwanted bleeding and breast tenderness and sensitivity. The risks and benefits of using hormone replacement therapy should be explained to postmenopausal women so that they can make an informed decision about using this treatment.
Persistent Identifierhttp://hdl.handle.net/10722/173230
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorHaines, CJen_HK
dc.contributor.authorFan, Sen_HK
dc.contributor.authorTang, GWKen_HK
dc.contributor.authorTang, LCHen_HK
dc.date.accessioned2012-10-30T06:28:39Z-
dc.date.available2012-10-30T06:28:39Z-
dc.date.issued1999en_HK
dc.identifier.citationHong Kong Medical Journal, 1999, v. 5 n. 2, p. 195-199en_HK
dc.identifier.issn1024-2708en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173230-
dc.description.abstractObjective. To establish guidelines on the administration of hormone replacement therapy in Hong Kong for a primary audience of Fellows and Members of the Hong Kong College of Obstetricians and Gynaecologists and a secondary audience of all interested medical and paramedical personnel in Hong Kong. Participants. The Quality Assurance Committee established a consensus panel of four College Fellows who had expertise of treating menopausal women by giving hormone replacement therapy. All the panelists were qualified obstetricians and gynaecologists. Evidence. The panelists drew their conclusions from the available scientific literature on hormone replacement therapy from Hong Kong and overseas. Consensus process. The consensus reached within the panel was presented to the Quality Assurance Committee on 23 June 1998, and subsequently revised and presented three times. The final version was approved by the Quality Assurance Committee on 2 March 1999 and the Council of the Hong Kong College of Obstetrics and Gynaecology on 11 March 1999. Conclusions. The administration of hormone replacement therapy is effective in reducing the severity and frequency of menopausal hot flushes and sweating. Therapy protects against osteoporosis and reduces the risk of cardiovascular disease. There is some evidence to suggest that treatment also protects against Alzheimer's disease and carcinoma of the colon. The most serious problem attributed to using hormone replacement therapy is the possible increase in the risk of breast cancer development; the exact risk is unknown. Side effects include unwanted bleeding and breast tenderness and sensitivity. The risks and benefits of using hormone replacement therapy should be explained to postmenopausal women so that they can make an informed decision about using this treatment.en_HK
dc.languageengen_US
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hken_HK
dc.relation.ispartofHong Kong Medical Journalen_HK
dc.subjectEstrogen replacement therapyen_HK
dc.subjectHong Kongen_HK
dc.subjectPractice guidelinesen_HK
dc.titleGuidelines for the administration of hormone replacement therapy. The Hong Kong College of Obstetricians and Gynaecologistsen_HK
dc.typeArticleen_HK
dc.identifier.emailTang, GWK: gwktang@hkucc.hku.hken_HK
dc.identifier.emailTang, LCH: lchtang@hku.hken_HK
dc.identifier.authorityTang, GWK=rp00328en_HK
dc.identifier.authorityTang, LCH=rp01756en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-0032826972en_HK
dc.identifier.volume5en_HK
dc.identifier.issue2en_HK
dc.identifier.spage195en_HK
dc.identifier.epage199en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridHaines, CJ=35884956100en_HK
dc.identifier.scopusauthoridFan, S=55429596200en_HK
dc.identifier.scopusauthoridTang, GWK=7401633864en_HK
dc.identifier.scopusauthoridTang, LCH=7402081111en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats